Julie So-Young Kim

CEO - Elect; Director, President and CEO · 3 filings · Latest: Aug 10, 2026

TAKEDA PHARMACEUTICAL CO LTD

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TAK	Julie So-Young Kim	Director, President and CEO	Aug 10, 2026	Sale	$17.10	89,090	$1.5M	391,489	Aug 13 1:27 AM
TAK	Julie Kim	—	Jul 13, 2026	Proposed Sale	$16.75	96,558	$1.6M	—	Jul 13 10:07 AM
TAK	Julie Kim	—	Jul 9, 2025	Proposed Sale	$15.42	58,559	$903.0K	—	Jul 9 10:34 AM